Micronutrients can prevent mutation and cancer
A paper (J Nucleic Acids 2010 Sep 22; pii 725071 and also in the prestigious peer reviewed Pubmed) from the Nutrition and Metabolism Center at the Children’s Hospital, Oakland, California (Ames B N ) has summarised three of their recent research studies and concluded that optimising micronutrient intake will in turn optimise metabolism, decrease DNA damage and result in less cancer as well as other degenerative diseases associated with ageing.
The three studies looked at
The delay of mitochondrial decay through ageing and free-radical damage could be minimised by supplementation with lipoic acid and acetyl carnitine.
How even modest micronutrient deficiencies (common in much of the population) accelerate molecular aging, including DNA damage and mitochondrial decay. This work included an in-depth analysis of vitamin K that suggests the importance of achieving optimal micronutrient intake for longevity.
The finding that a loss of enzyme function can result from protein deformation and loss of function due to an age-related decline in membrane fluidity or mutation. The loss of enzyme function can be compensated by a high dietary intake of any of the B vitamins.
Researchers concluded that ‘optimising micronutrient intake could have a major effect on the prevention of cancer and other degenerative diseases of ageing’.
Ed: Short, but sweet. So, with this in mind I urge readers to be more aware of the weakened levels of vitamins allowed in your High Street, EU-approved supplements – like B complex; then there´s the increasiing usage of synthetic copies of the natural, real compound; the common Western population deficiency in vitamin K levels (due to low consumption of ‘greens’ and low levels of beneficial bacteria in the gut); and the EU-mandated restriction of key trace minerals in mass market supplements.
This constant ´dumbing down´ of supplements on the High Street by the EU flies in the face of the latest research, as you can see for yourselves in the above example.
